Gilead Sciences, Inc. (ETR:GIS)
96.83
-0.23 (-0.24%)
May 30, 2025, 5:35 PM CET
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
€1,510,547
Profits / Employee
€313,569
Market Cap
121.64B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 90,587 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
Gilead Sciences News
- 4 days ago - Gilead Sciences' Best Days May Be Ahead - Here's Why - Seeking Alpha
- 7 days ago - Gilead succeeds in late-stage trial for breast cancer therapy Trodelvy as a first line option - Seeking Alpha
- 7 days ago - ASCENT-03: Trodelvy Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors - Wallstreet:Online
- 7 days ago - ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors - Business Wire
- 7 days ago - Final Trade: WMT, GILD, DECK, ROST - CNBC
- 8 days ago - Gilead to buy certain Hookipa Pharma assets for up to $10M - Seeking Alpha
- 8 days ago - Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript) - Seeking Alpha
- 10 days ago - Tomas Cihlar, Gilead Sciences, Named to TIME’s List of 100 Most Influential People in the World for HIV Research - Wallstreet:Online